FORMULATION AND CHARACTERISATION OF MELOXICAM LOADED EMULGEL FOR TOPICAL APPLICATION

  • Arti Pednekar Department of Pharmaceutics, KLES College of Pharmacy, JNMC Campus Belagavi Karnataka 590010, India
  • Panchaxari Dandagi KLES College of Pharmacy, JNMC Campus Belagavi Karnataka
  • Anand Gadad KLES College of Pharmacy, JNMC Campus Belagavi Karnataka
  • Vinayak Mastiholimath KLES College of Pharmacy, JNMC Campus Belagavi Karnataka

Abstract

Objective: The aim of the research work is to formulate emulgel of Meloxicam for topical application.

Methods: The method used for preparation of microemulsion was water titration method with Oleic acid as oil phase, Tween 20 as surfactant and PEG 400 as co-surfactant and its concentrations were fixed based on Pseudoternary phase diagrams. The optimized emulsion formulation was incorporated into the gel matrix that is Carbopol981 NF and Carbopol 974 P NF.

Results: The prepared emulsions were characterized for globule size, drug content, zeta potential and the emulgel for physical appearance, drug content, pH, viscosity, spreadability, extrudability and in vitro drug release studies. The optimized emulsion formulations E1 and F1 showed globule size of 176 nm and 128 nm respectively and the emulgel formulation M2F1 with 1.5% Carbopol 981 and optimized F1 emulsion formulation showed in vitro drug release of 89.934% at the end of 8 h. The optimized formulation showed no skin irritation when compared with standard irritant 0.8% of Formalin. The optimized formulation showed better anti-inflammatory effect when compared with marketed formulation.

Conclusion: Meloxicam was proven to be a suitable candidate for formulating emulgel for topical delivery to achieve better patient compliance.

 

Keywords: Meloxicam, Emulgel, Topical application, Carbopol 981NF, Carbopol 974 P NF, Oleic acid, Tween 20 and PEG 400

Downloads

Download data is not yet available.

References

1. Drug Bank. Meloxicam; 2014. Available from: http://www.drugbank.ca/system/fdalabels/DB00814.pdf 1265922796. [Last accessed on 2015 Feb 07].
2. Sonaje SP, Gondkar BS, Saudagar BR. Gellified emulsion: a new born formulation for topical delivery of hydrophobic drugs. World J Pharm Pharm Sci 2013;3:233-51.
3. Joshi B, Singh G, Rana AC, Saini S, Singla V. Emulgel: a comprehensive review on the recent advances in topical drug delivery. Int Res J of Pharm 2011;2:66-70.
4. Sah AK, Jain SK, Pandey RS. Microemulsion based hydrogel formulation of Methoxsalen for the effective treatment of psoriasis. Asian J Pharm Clin Res 2011;4:140-5.
5. Prajapati SK. Novel nanoemulsion as vehicles for transdermal delivery of clozapine : in vitro and in vivo studies. Int J Pharm Pharm Sci 2013;5:126-34
6. Abd-allah FI, Dawaba HM, Ahmed AMS. Development of a microemulsion-based formulation to improve the availability of poorly water-soluble drug. Drug Discoveries Ther 2010;4:257–66.
7. Abd-allah FI, Dawaba HM, Mansour A, Samy AM. Evaluation of the anti-inflammatory and analgesic effects of Piroxicam–loaded microemulsion in topical formulations. Int J Pharm Pharm Sci 2011;3:66-70.
8. K Sachan R, Khatri K, Rishi K, Singh R, Katare OP. Self-emulsifying drug delivery system: a novel approach for enhancement of bioavailability. Int J PharmTech Res 2010;2:1738-45.
9. Singla V, Saini S, Rana AC, Singh G. Development and evaluation of topical emulgel of lornoxicam using different. Int Pharm Sci 2012;2:38-44.
10. Kaur LP, Guleri TK, Topical Gel. A recent approach for novel drug delivery. Asian J Biomed Pharm Sci 2013;3:1–5.
11. Ghodekar SV, Chaudhari SP, Ratnaparakhi MP. Development and characterization of silver sulfadiazine emulgel for topical drug delivery. Int J Pharm Pharm Sci 2012;4:305-16.
12. Dadwal M, Mittal PP, Rana S. Formulation development and evaluation of Indomethacin emulgel. Int J Res Dev 2014;5:81–8.
13. Kumar KJR, Muralidharan S, Dhanaraj SA. Anti-fungal activity of microemulsion based Fluconazole gel for onychomycosis against Aspergillus Niger. Int J Pharm Pharm Sci 2012;5:3–9.
14. Khullar R, Kumar D, Seth N, Saini S. Formulation and evaluation of Mefenamic acid emulgel for topical delivery. Saudi Pharm J 2012;20:63-7.
15. Sravan VN, Varma K, Maheshwari PV, Navya M, Reddy SC, Shivakumar HG, et al. Calcipotriol delivery into the skin as emulgel for effective permeation. Saudi Pharm J 2014;22:591-9.
16. Bhandari N, Verma P, Sing H. Proniosomes: a surrogate for transdermal drug delivery. Int J Pharm Res Bio Sci 2012;1:10-26.
17. Lobo MS, Costa P. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123-33.
18. Ahmed OAA, Badr-eldin SM, Ahmed TA. Kinetic study of the in vitro release and stability of Theophylline floating beads. Int J Pharm Pharm Sci 2013;5:1–6.
Statistics
831 Views | 2272 Downloads
How to Cite
Pednekar, A., P. Dandagi, A. Gadad, and V. Mastiholimath. “FORMULATION AND CHARACTERISATION OF MELOXICAM LOADED EMULGEL FOR TOPICAL APPLICATION”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 7, no. 11, Sept. 2015, pp. 216-22, https://innovareacademics.in/journals/index.php/ijpps/article/view/7397.
Section
Original Article(s)